The John D. Baxter Prize for Entrepreneurship was established to recognize the extraordinary achievement of bringing an idea, product, service, or process to market; which ultimately elevates the field of endocrinology, and positively impacts the health of patients.
The award recipient of the biennially Baxter Prize receives a $50,000 award, the John D. Baxter Medal for Entrepreneurship, and global acclaim. The winner will be awarded at the Society's annual meeting ENDO 2023, June 15-18, 2023, Chicago, IL, the largest gathering in the world of endocrinologist and professionals working in hormone health.
R. Scott Struthers, PhD, has been awarded the Society’s John D. Baxter Prize for Entrepreneurship for his contributions to drug discovery and development programs for endocrine diseases. The award recognizes extraordinary achievement of bringing an idea, product, service, or process to market. This work ultimately elevates the field of endocrinology and positively impacts the health of patients.
Struthers is recognized also for his entrepreneurship in founding companies, including Crinetics Pharmaceuticals, and leading the team that created a first-in-class therapy for the treatment of endometriosis and uterine fibroids during his time at Neurocrine Biosciences, Inc.
As a founder and CEO of Crinetics Pharmaceuticals Inc., Struthers built an important company that is developing much-needed therapies for people with endocrine disorders such as acromegaly, carcinoid syndrome, Cushing’s disease, congenital adrenal hyperplasia and congenital hyperinsulinism. He is also a founder of Radionetics Oncology, which focuses on novel radiotherapeutics to treat a wide range of cancers. Struthers also co-founded the San Diego Entrepreneurs Exchange, a nonprofit organization that provides networking and resources for early-stage start-ups.
| Year | Recipient | Institution |
|---|---|---|
| 2020 | Daniel J. Drucker, MD | Mt. Sinai Hospital, Toronto, Ontario, Canada |
| 2018 | André Ulmann, MD, PhD | HRA Pharma (Global) |
John D. Baxter, MD, was a renowned endocrinologist who rose to prominence as a researcher with breakthroughs in molecular biology and early recombinant DNA technology, leading to the first successful gene cloning for rat, bovine, and human growth hormone. His dedication to scientific and clinical research garnered numerous awards and recognition. As President of the Endocrine Society from 2002 – 2003, Dr. Baxter shared his passion for advancing research that would lead to effective clinical applications.
Nomination packages must be submitted as a single file in the nomination form and must include:
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.